Completely agree tarecq. Our NASH pipeline will be worth more than Tobira, never mind Cdiff, which itself should be over $1billion market cap. Add to this existing products that a Bigpharama can quickly increase revenues & along with opportunities in Diabetes. I think a Buyout price of $4 billion to $5billion seems reasonable for Immuron in late 2017, early 2018.
- Forums
- ASX - By Stock
- IMC
- $1.7 billion overnight
$1.7 billion overnight, page-5
-
- There are more pages in this discussion • 2 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add IMC (ASX) to my watchlist
|
|||||
Last
9.6¢ |
Change
-0.002(2.04%) |
Mkt cap ! $21.88M |
Open | High | Low | Value | Volume |
9.6¢ | 9.6¢ | 9.5¢ | $10.34K | 108.6K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
2 | 84702 | 9.2¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
9.8¢ | 37295 | 2 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
2 | 84702 | 0.092 |
4 | 221455 | 0.090 |
1 | 90000 | 0.089 |
2 | 61363 | 0.088 |
1 | 32500 | 0.085 |
Price($) | Vol. | No. |
---|---|---|
0.098 | 37295 | 2 |
0.100 | 750 | 1 |
0.105 | 92462 | 3 |
0.110 | 208068 | 1 |
0.115 | 119000 | 2 |
Last trade - 11.39am 07/08/2024 (20 minute delay) ? |
Featured News
IMC (ASX) Chart |